Published preclinical work has described: Reduced de novo lipogenesis in adipocytes Reduced hepatic lipogenesis in diet-induced obesity models Improved adipose tissue metabolic markers Licensed Healthcare Practitioners 1,000+ physician-grade products, bulk-tier pricing, and direct shipping to your practice
Lack of Awareness: The Pernicious Anaemia Society and other patient advocacy groups have highlighted that some GPs and nurses may not be fully up-to-date on the latest guidelines or may misinterpret them
Potential Benefits: A Summary Based on the available (predominantly preclinical) literature, the following potential benefits have been identified: Risks & Safety Considerations Known & Reported Side Effects Because large-scale human trials are lacking, our understanding of the side effect profile is limited
Researchers observed reduced brain damage in animal stroke models given BPC-157, pointing toward possible cognitive benefits
"Brain-gut Axis and Pentadecapeptide BPC 157: Theoretical and Practical Implications." Current Neuropharmacology, 2016;14(8):857-865
